By Professor Susan Jane Connor

Conference Papers

Hanna L; Joshi S; Capstick R; Ramsden J; Lawrence S; Robinson D; Alexander J; Sahnan K; Warusavitarne J; Connor S; Lung P; Tozer P; Hart A, 2026, 'O26 Developing a treat-to-target framework for perianal crohn’s disease: an international initiative from the TOpClass consortium', BMJ, pp. a16.2 - a1a17, presented at Oral Abstracts, http://dx.doi.org/10.1136/gutjnl-2026-bsg.25

Liu S; Wu R; Wilson B; Caquilpan V; Connor SJ; Andrews JM, 2025, 'Colectomy trends in ulcerative colitis amidst an expanding therapeutic landscape: Insights from a clinical care registry', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 107 - 107

Pudipeddi A; Paramsothy S; Kariyawasam V; Paramsothy R; Ghaly S; Haifer C; An Y-K; Begun J; Connor SJ; Corte C; Ward MG; De Cruz P; Fung C; Redmond D; Chan W; Mourad F; Kermeen M; Leong RW, 2025, 'Complete disease clearance as a novel composite endpoint to predict long-term relapse in vedolizumab-treated patients with ulcerative colitis: A post-hoc analysis from the VIEWS randomised controlled trial', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 92 - 92

Wu R; Caquilpan V; Wilson W; Andrews JM; Connor SJ, 2025, 'Divided by distance: Insights into regional disparities in inflammatory bowel disease care across Australia from the Crohn's Colitis Cure Data Insights Program', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 108 - 110

Seng C; Wu R; Su WK; Wilson W; Connor SJ; Andrews JM; Walker G, 2025, 'Older-onset inflammatory bowel disease: How are we managing this specialty cohort in Australasia? Crohn's Colitis Cure Data Insights Program', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 112 - 113

Wu R; Su WK; Wilson W; Connor SJ; Andrews JM, 2025, 'Real-world patterns in the route of administration of infliximab and vedolizumab for inflammatory bowel disease: Clinician inertia?', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 117 - 118

Wu R; Su WK; Wilson W; Deschenes R; Connor SJ; Andrews JM, 2025, 'Real-world persistence of biologic therapies in Crohn's disease: Insights from the Crohn's Colitis Care registry and comparison with the Persistence Australia National Inflammatory Bowel Disease Cohort (PANIC) registry', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 89 - 90

Wu R; Wilson W; Caquilpan V; Connor SJ; Andrews JM, 2025, 'Real-world trends in infliximab use and route switching in inflammatory bowel disease in Australia from 2021 to 2024: Insights from Crohn's Colitis Cure Data Insights Program', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 113 - 114

Wu R; Petch B; Deschenes R; Connor SJ; Andrews JM, 2025, 'The likely return on investment from broad implementation of an inflammatory bowel disease-specific clinical quality registry: Towards sustainable inflammatory bowel disease care', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 118 - 119

Su WK; Connor SJ; Andrews JM; Wilson W, 2025, 'The short Crohn's Disease Activity Index (CDAI) is a reliable measure of clinical disease activity and practical alternative to the full CDAI and Harvey-Bradshaw Index in real-world inflammatory bowel disease practice', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 85 - 86

Pipicella JL; Gu B; Palmer LJ; Connor SJ; Wilson WE; Andrews JM, 2024, 'ASSESSING PATIENT-PERCEIVED BURDEN OF DISEASE IN CROHN'S DISEASE: A NOVEL SCORING APPROACH IN A REAL-WORLD AUSTRALASIAN COHORT', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S1444 - S1445, presented at Digestive Disease Week (DDW), DC, Washington, 18 May 2024 - 21 May 2024

Gu B; Pipicella JL; Palmer LJ; Connor SJ; Wilson WE; Andrews JM, 2024, 'ASSESSING PATIENT-PERCEIVED BURDEN OF DISEASE IN ULCERATIVE COLITIS: A NOVEL SCORING APPROACH IN A REAL-WORLD AUSTRALASIAN COHORT', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S1444 - S1444, presented at Digestive Disease Week (DDW), DC, Washington, 18 May 2024 - 21 May 2024

Alshiwanna B; McNamara J; Wilson WE; Pipicella JL; Ghaly S; Gearry R; Begun J; Williams A-J; Lynch KD; Lawrance IC; Schultz M; Walker GJ; Radford-Smith GL; Connor SJ; Andrews JM, 2024, 'DOSE ESCALATED INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S1135 - S1135, presented at Digestive Disease Week (DDW), DC, Washington, 18 May 2024 - 21 May 2024

Barnett MI; McNamara J; Wilson WE; Pipicella JL; Ghaly S; Gearry R; Begun J; Williams A-J; Lynch KD; Lawrance IC; Schultz M; Walker GJ; Radford-Smith GL; Connor SJ; Andrews JM, 2024, 'DOSE ESCALATED USTEKINUMAB IN INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S1134 - S1135, presented at Digestive Disease Week (DDW), DC, Washington, 18 May 2024 - 21 May 2024

McNamara J; Alshiwanna B; Wilson WE; Pipicella JL; Ghaly S; Gearry R; Begun J; Ng W; Lynch KD; Lawrance IC; Schultz M; Walker GJ; Radford-Smith GL; Andrews JM; Connor SJ, 2024, 'DOSE ESCALATED VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S1135 - S1135, presented at Digestive Disease Week (DDW), DC, Washington, 18 May 2024 - 21 May 2024

De Gregorio M; Winata LS-H; Hartley I; Behrenbruch CC; Connor SJ; D'Souza B; Basnayake C; Guerra GR; Johnston MJ; Kamm MA; Keck JO; Lust M; Niewiadomski O; Ong EJ; Schulberg JD; Srinivasan A; Sutherland T; Woods R; Wright EK; Connell W; Thompson A; Ding NS, 2024, 'IMPROVED CLINICAL AND RADIOLOGIC HEALING OF CROHN'S PERIANAL FISTULAS USING A NOVEL COORDINATED CARE MODEL OPTIMISING MEDICAL AND SURGICAL TREATMENTS: A PROSPECTIVE REAL-WORLD OBSERVATIONAL STUDY', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S1126 - S1127, presented at Digestive Disease Week (DDW), DC, Washington, 18 May 2024 - 21 May 2024

McNamara J; Wilson WE; Pipicella JL; Ghaly S; Gearry R; Williams A-J; Lynch KD; Lawrance IC; Schultz M; Walker GJ; Radford-Smith GL; Connor SJ; Andrews JM, 2024, 'THE BURDEN OF MENTAL HEALTH DISEASE IN PEOPLE WITH INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S854 - S855, presented at Digestive Disease Week (DDW), DC, Washington, 18 May 2024 - 21 May 2024

Pipicella JL; McNamara J; Wilson WE; Lynch KD; Walker GJ; Begun J; Lawrance IC; Ghaly S; Radford-Smith GL; Williams A-J; Gearry R; Schultz M; Brett L; Andrews JM; Connor SJ, 2024, 'THE REAL-WORLD USE OF FIVE-AMINOSALICYLATE (5ASA) TREATMENT FOR ULCERATIVE COLITIS IN AUSTRALIA AND NEW ZEALAND: CROHN'S COLITIS CURE (CCC) DATA INSIGHT'S PROGRAM', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S1456 - S1457, presented at Digestive Disease Week (DDW), DC, Washington, 18 May 2024 - 21 May 2024

Khoo E; Amiss A; Ding NS; Bryant RV; Mohsen W; Connor SJ; Leong R; Croft A; Lynch KD; Sparrow M; De Cruz P; An Y-K; Holtmann GJ; Begun J, 2024, 'TOFACITINIB DEMONSTRATES PRELIMINARY EFFICACY IN INDUCTION OF REMISSION IN CHRONIC POUCHITIS', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S216 - S217, presented at Digestive Disease Week (DDW), DC, Washington, 18 May 2024 - 21 May 2024

McNamara J; Wilson WE; Pipicella JL; Ghaly S; Gearry R; Begun J; Ng W; Lynch KD; Lawrance IC; Schultz M; Walker GJ; Radford-Smith GL; Andrews JM; Connor SJ, 2024, 'VARIATION IN OUTCOMES IN INFLAMMATORY BOWEL DISEASE AT TEN AUSTRALASIAN CENTRES - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S839 - S839, presented at Digestive Disease Week (DDW), DC, Washington, 18 May 2024 - 21 May 2024

Taxonera C; Ha C; Fortes MDP; Gardiner S; Mundayat R; Ghosh S; Connor SJ, 2023, 'Characterisation of hospitalised patients with ulcerative colitis treated with tofacitinib in the OCTAVE clinical programme for up to 7.8 years', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, pp. 678 - 679

McNamara J; Pipicella JL; Connor SJ; Andrews JM, 2023, 'IDDF2023-ABS-0141 The evolving role of technology in delivering patient-centric care in inflammatory bowel disease – an australasian experience using crohn’s colitis care e-health patient portal', BMJ, pp. a203.1 - a2a203, presented at Clinical Gastroenterology, http://dx.doi.org/10.1136/gutjnl-2023-iddf.193

McNamara J; Andrews JM; Connor SJ; Pipicella JL; Wilson W, 2023, 'IDDF2023-ABS-0146 Disease and treatment factors influencing outcomes in fistulising crohn’s disease', BMJ, pp. a203.2 - a2a204, presented at Clinical Gastroenterology, http://dx.doi.org/10.1136/gutjnl-2023-iddf.194

Pipicella JL; Karimi N; Wang G; Willmann L; Descallar J; O’Connor K; Connor S; Leung Y; Huang V; Williams A-J, 2021, 'IDDF2021-ABS-0062 A novel decision aid improves knowledge and quality of pregnancy-related decision-making in IBD', in Gut, BMJ, pp. a108 - a108, presented at Clinical Gastroenterology, http://dx.doi.org/10.1136/gutjnl-2021-iddf.126

Dunning A; Sechi A; Williams A; Connor S; Ng W; Kuzet G; Cabaero A, 2019, 'Use of a novel tool to identify nutritional risk in an inflammatory bowel disease outpatient service: Liverpool IBD-Nutrition Screen', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 200 - 200, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100314&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Armuzzi A; Kayhan C; Panaccione R; Watanabe K; Molander P; Rubin DT; Peyrin-Biroulet L; Melmed G; Connor S; Colombel J-F; Dubinsky M, 2019, 'P005 DELAY IN DIAGNOSIS OF ULCERATIVE COLITIS: RESULTS OF A GLOBAL ULCERATIVE COLITIS NARRATIVE SURVEY', in Inflammatory Bowel Diseases, Oxford University Press (OUP), pp. s4 - s4, http://dx.doi.org/10.1093/ibd/izy393.008

Schreiber S; Panaccione R; Kayhan C; Lopez-Sanroman A; Peyrin-Biroulet L; Armuzzi A; Dubinsky M; Melmed G; Rubin M; Connor S; Keefer L; Rubin DT, 2019, 'P023 PATIENT AND HEALTHCARE PROFESSIONAL VIEWS ON EMOTIONAL HEALTH AND INTIMACY IN ULCERATIVE COLITIS: RESULTS OF A GLOBAL ULCERATIVE COLITIS NARRATIVE SURVEY', in Inflammatory Bowel Diseases, Oxford University Press (OUP), pp. s12 - s12, http://dx.doi.org/10.1093/ibd/izy393.027

Lord A; Mortlock S; Montgomery G; Simms LA; Krishnaprasad K; Hanigan K; Doecke JD; Gearry R; Lawrance I; Bampton PA; Andrews JM; Mahy G; Connor SJ; Sparrow M; Bell S; Walsh A; Radford-Smith GL, 2018, 'Genetically distinct signatures of mild and severe ulcerative colitis', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 103 - 104, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530647800176&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Little RD; Chu IE; van der Zanden EP; Flanagan E; Bell SJ; Sparrow MP; Shelton E; Connor SJ; Roblin X; Ward MG, 2018, 'Is there a difference in adalimumab drug levels according to pen versus syringe use: An international, multicenter retrospective analysis', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 102 - 102, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530647800175&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Connor S; Sechi A; Witcombe D; Fox H, 2018, 'YUlcerative Colitis (UC) Narrative Study Australian data: A survey to compare patient and physician perspectives on communication and management of UC', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 105 - 106, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530647800179&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Krishnaprasad K; Walsh A; Begun J; Bell S; Carter D; Grafton R; Sechi A; Sewell K; McMahon A; Connor SJ; Radford-Smith GL; Andrews JM, 2018, 'CROHN'S COLITIS CARE (CCCARE) - DEVELOPMENT AND TESTING OF A BESPOKE CLOUD-BASED CLINICAL MANAGEMENT SYSTEM FOR INFLAMMATORY BOWEL DISEASE (IBD)', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S892 - S892, presented at Annual Meeting of the American-Society-for-Gastrointestinal-Endoscopy / Digestive Disease Week, DC, Washington, 02 June 2018 - 05 June 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000450011103425&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lord A; Mortlock S; Montgomery G; Simms L; Krishnaprasad K; Hanigan K; Doecke JD; Gearry R; Lawrance I; Bampton PA; Andrews JM; Mahy G; Connor SJ; Sparrow M; Bell S; Walsh A; Radford-Smith GL, 2018, 'GENETICALLY DISTINCT SIGNATURES OF MILD AND SEVERE ULCERATIVE COLITIS', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S1025 - S1025, presented at Annual Meeting of the American-Society-for-Gastrointestinal-Endoscopy / Digestive Disease Week, DC, Washington, 02 June 2018 - 05 June 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000450011104106&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Paramsothy S; Kamm MA; Nielsen S; Deshpande N; Faith J; Clemente JC; Paramsothy R; Walsh A; van den Bogaerde J; Samuel D; Leong RW; Connor SJ; Ng WSW; Lin E; Wilkins M; Colombel JF; Borody TJ; Mitchell HM; Kaakoush NO, 2018, 'IN FECAL MICROBIOTA TRANSPLANTATION (FMT) FOR ULCERATIVE COLITIS, FUSOBACTERIUM IS ASSOCIATED WITH LACK OF REMISSION, WHILE METABOLIC SHIFTS TO STARCH DEGRADATION AND SHORT CHAIN FATTY ACID PRODUCTION ARE ASSOCIATED WITH REMISSION - RESULTS FROM THE RANDOMIZED CONTROLLED FOCUS STUDY', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S35 - S35, presented at Annual Meeting of the American-Society-for-Gastrointestinal-Endoscopy / Digestive Disease Week, DC, Washington, 02 June 2018 - 05 June 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000450011100099&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pulusu SSR; Srinivasan A; Krishnaprasad K; Cheng D; Mogilevski T; Flanagan E; Keung C; Wu Y; Prosser R; Sawyer EA; Rizvi Q-U-A; Su HY; Leung WK; Edmundson A; Cooke S; Mahy G; Thin L; Radford-Smith GL; Sparrow M; Andrews JM; Connor SJ; Bampton PA; Simon G; van Langenberg DR; Bell S; De Cruz P; Begun J; Ng SC; Travis SP; Lawrance I, 2018, 'VEDOLIZUMAB(VDZ) REAL WORLD OUTCOMES IN ULCERATIVE COLITIS (UC)', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S836 - S836, presented at Annual Meeting of the American-Society-for-Gastrointestinal-Endoscopy / Digestive Disease Week, DC, Washington, 02 June 2018 - 05 June 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000450011103257&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Wen A; Selvanderan SP; Wu Y; Xuan W; Andrews JM; Koo JH; Ng W; Connor S, 2017, 'Assessment of anti-tumor necrosis factor drug levels in people with Crohn's disease changes management decisions more often when done for loss of response than during remission', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 152 - 152, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100271&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lin B; Wu Y; Thilakanathan C; Lehmann P; Xuan W; Mohsen W; Toong C; Ng W; Connor S, 2017, 'Biological level testing in inflammatory bowel disease identifies inappropriate use of infliximab, with substantial associated cost savings', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 132 - 133, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100240&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Seang S; Kanazaki R; Krishnaprasad K; Hanigan K; Bampton P; Prosser R; Andrews J; Grafton R; Mahy G; Bell S; Xuan W; Ng W; Sparrow M; Walsh A; Radford-Smith G; Connor S, 2017, 'Clinical predictors of severe ulcerative colitis requiring colectomy in Australia', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 145 - 145, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100259&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Krishnaprasad K; Walsh A; Begun J; Bell S; Carter D; Grafton R; Sechi A; Sewell K; Mcmahon A; Connor S; Radford-Smith G; Andrews JM, 2017, 'Crohn's Colitis Care (CCCare): A bespoke cloud-based clinical management system for inflammatory bowel disease - development and beta testing', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 131 - 131, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100237&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Verdon C; Sawyer E; Connor S; Ng W; Turner I, 2017, 'Drug-induced systemic lupus erythematosus in patients with inflammatory bowel disease treated with anti-tumor necrosis factor inhibitors: A case series', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 150 - 150, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100268&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Wu Y; Lin B; Thilakanathan C; Lehmann P; Xuan W; Mohsen W; Toong C; Ng W; Connor S, 2017, 'Secondary loss of response is the most common indication for infliximab level testing in inflammatory bowel disease: The Australian experience', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 153 - 154, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100273&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mitrev N; Vande Casteele N; Seow C; Andrews JM; Connor SJ; Moore G; Barclay M; Begun J; Bryant R; Chan W; Corte C; Ghaly S; Lemberg DA; Kariyawasam V; Lewindon P; Martin J; Mountifield R; Radford-Smith G; Slobodian P; Sparrow M; Toong C; Van Langenberg D; Ward MG; Leong RW, 2017, 'Therapeutic drug monitoring-guided biological drug therapy in inflammatory bowel disease: Consensus statements of the Australian Inflammatory Bowel Disease Association (AIBDA) and Gastroenterological Society of Australia (GESA)', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 136 - 138, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100247&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Nguyen MTA; Antoniades S; Xuan W; Ghaly S; Connor S; Ng W, 2017, 'Treatment of ulcerative colitis with infliximab: Real-world outcomes are better than pivotal trials and improved with dose intensification', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 139 - 139, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100249&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pulusu SSR; Krishnaprasad K; Cheng D; Mogilevski T; Flanagan E; Parthasarathy N; Wu C; Prosser R; Sawyer E; Rizvi QUA; Taylor K; Cooke S; Mahy G; Sparrow M; Andrews J; Connor S; Bampton P; Ghaly S; Van Langenberg D; Bell S; De Cruz P; Begun J; Lawrance I, 2017, 'Vedolizumab: Real-life outcomes to therapy in Crohn's disease', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 143 - 143, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100256&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pulusu SSR; Krishnaprasad K; Cheng D; Mogilevski T; Flanagan E; Parthasarathy N; Wu C; Prosser R; Sawyer E; Rizvi Q-U-A; Taylor K; Sewell K; Cooke S; Mahy G; Radford-Smith G; Sparrow M; Andrews J; Connor S; Bampton P; Ghaly S; Van Langenberg D; Bell S; De Cruz P; Begun J; Lawrance I, 2017, 'Vedolizumab: Real-life outcomes to therapy in ulcerative colitis', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 142 - 142, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100255&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lawrance IC; Baird A; Lightowler D; Radford-Smith G; Andrews JM; Connor S, 2017, 'A multi-centre double blind randomised placebo-controlled study of the use of rectal tacrolimus in the treatment of resistant ulcerative proctitis', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, pp. S4 - S5

Sechi A; Sawyer E; Ng W; Connor S, 2016, 'Proving cost effectiveness through implementation of a nurse-led inflammatory bowel disease patient advice line and virtual clinic (CHEAP)', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 174 - 174, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000384664700314&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Paramsothy S; Kaakoush NO; Kamm M; Faith J; Clemente JC; Walsh A; van den Bogaerde J; Samuel D; Leong R; Connor S; Ng W; Paramsothy R; Lin E; Colombel J; Borody T; Mitchell HM, 2016, 'Effect on the intestinal microbiota and clinical outcome of faecal microbiota transplantation in patients with UC', in HELICOBACTER, WILEY-BLACKWELL, GERMANY, Magdeburg, pp. 72 - 72, presented at 29th International Workshop on Helicobacter and Microbiota in Inflammation and Cancer, GERMANY, Magdeburg, 15 September 2016 - 17 September 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383517600017&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sechi A; Sawyer E; Ng W; Connor S, 2016, 'Proving cost effectiveness through implementation of a nurse-led inflammatory bowel disease patient advice line and virtual clinic (CHEAP)', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, pp. S494 - S494, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000374496600879&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Paramsothy S; Kamm MA; Walsh A; van den Bogaerde J; Samuel D; Leong RW; Connor SJ; Ng WSW; Paramsothy R; Kaakoush N; Mitchell HM; Xuan W; Lin E; Borody T, 2016, '600 Multi Donor Intense Faecal Microbiota Transplantation is an Effective Treatment for Resistant Ulcerative Colitis: A Randomised Placebo-Controlled Trial', in Gastroenterology, Elsevier, pp. s122 - s123, http://dx.doi.org/10.1016/s0016-5085(16)30517-0

Hsu J; Greenup A; Kordian T; Sze K; Bassan M; Koo K; Ng W; Connor S, 2015, 'A single-blinded, randomised clinical trial: comparison between 2 different bowel preparation formulations split PrepKitC, a combined polyethylene glycol and sodium picosulfate-based solution and split prep Moviprep, a polyethylene glycol-based solution in the setting of outpatient colonoscopy', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 45 - 45, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000364505900088&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page